of medulloblastoma with melanotic and myogenic differentiation Complete Rhabdomyoblastic in a Leptomeningeal Metastatic Drop Medulloblastoma- Case Report Medulloblastoma: clinicopathological parameters, risk stratification,

Is there a role for adjuvant therapy in patients being treated with epoetin

The ALOX12 gene is located on human chromosome 17p13.1, a common location for monoallelic deletions in cancers

A single dose of vitamin D enhances immunity to Mycobacteria

We proposed at 428.202(g)(1) to codify the policy described in section 40.1.2 of the revised Medicare Part D Drug Inflation Rebate Guidance, whereby in cases where there are 1 or more quarter(s) in the payment amount benchmark period or applicable period for which a manufacturer has not reported units under section 1927(b)(3)(A)(iv) of the Act but has reported AMP under sections 1927(b)(3)(A)(i) and (ii) of the Act, CMS would calculate the benchmark period manufacturer price or AnMP, as applicable, using data only from quarter(s) with units